Search

We spoke with our members about the future of these precision techniques on a scale that is nearly invisible to the human eye, their current applications and the roadblocks to implementing them

Long-term vafidemstat treatment was safe and well tolerated with drug exposures up to 2 years Anti-inflammatory activity observed in vafidemstat-treated patients SATEEN was a pilot, small scale, trial

The company has focused on the study of circulating RNA for the early detection of cancer

The company conducted a retrospective study based on the records of patients hospitalized due to intrahepatic cholangiocarcinoma (iCCA) and treated in Spanish public and private hospitals between

The aim is to provide scientists and research centres with leading technology for data integration and analysis, while ensuring data control, ownership, and traceability

A new SEBBM group is looking to help researchers take their ideas to market through a sharing space

Mikel Irujo, Counsellor for Economic and Business growth, referred to Navarra’s leadership and highlights the importance of BIOSPAIN when promoting relationships between companies in Navarra and other

Proven technology poised to accelerate growth of emerging synthetic food space

The President of Navarra, María Chivite, states that this sector is strategic for economic recovery, with great potential for job creation

Algenex SL and FATRO S.p.A, a leader in the field of veterinary pharmaceutical products, have announced that the European Commission (EC) and the UK Veterinary Medicine Directorate (VMD), have granted

The start-ups Oxolife, Peptomyc and aptaTargets, with which GENESIS Biomed collaborates, are advancing in their maturity with the initiation and development of clinical phases and are approaching an

Gregory Rall, Senior Manager of Innovation and Technology at Invest HK, bronze sponsor of Biospain 2021, talked to us about the future and the importance of people to grow our sector

The company is based at the Barcelona Science Park and focuses on the discovery of new drugs aimed at therapeutic targets that, due to their structural properties, are currently considered

International Conference on Autism ICA-2021 BIOSPAIN 2021 34th European College Neuropsychopharmacology (ECNP) congress 2021 21st Sachs Annual Biotech in Europe Forum 2021 37th Congress of the

HOPE will be the first clinical trial in precision medicine with vafidemstat in neurodevelopmental diseases Multicentric study to assess the efficacy of vafidemstat in Kabuki syndrome patients

To mark World Alzheimer's Day, we spoke to Marta Barrachina, founder and CEO of ADmit Therapeutics, one of our partners who is seeking a way to perform an early diagnosis of this silent disease

Ysios Capital is the first specialized venture capital firm in life sciences globally and the first Spanish firm to achieve the Diversity VC Standard, an assessment and certification process that sets